期刊文献+

雷诺现象为首发表现的自身免疫性疾病疾病谱及临床特点 被引量:6

Subset of Disease and Clinical Features of Autoimmune Disease with the Initial Presentation of Raynaud's Phenomenon
下载PDF
导出
摘要 目的观察雷诺现象为首发临床表现的自身免疫性疾病疾病谱,以及其临床受累脏器的特点。方法选择2012年10月至2013年3月北京协和医院风湿免疫科门诊以雷诺现象为首发临床表现的自身免疫性疾病患者。除实验室常规检查外,所有患者均行胸部高分辨CT及超声心动图检查。结果共135例患者纳入研究,男9例,女126例,以系统性红斑狼疮(45.9%)、系统性硬化症(20.7%)及未分化结缔组织病(15.6%)最常见。系统受累以皮肤黏膜(97例,71.9%)、关节(86例,63.7%)及肺部受累(72例,53.3%)多见。其中合并肺间质病变者63例(46.7%),以系统性红斑狼疮(29例,46.8%)、系统性硬化症(17例,60.0%)及混合性结缔组织病(6例,83.3%)多见;合并肺动脉高压者37例(27.4%),以系统性红斑狼疮(16例,25.8%)、系统性硬化症(10例,35.7%)、未分化结缔组织病(4例,19.7%)及原发性干燥综合征(2例,28.6%)多见。结论雷诺现象可以是多种自身免疫性疾病的早期表现,尤其是系统性红斑狼疮及系统性硬化症。合并雷诺现象的患者更易出现肺部受累,尤其是肺间质病变及肺动脉高压,应重视在发病初期进行筛查。胸部高分辨CT及超声心动图检查分别是早期筛查肺间质病变及肺动脉高压的简便有效的方法。 To observe the subset of disease and clinical features of patients with Raynaud' s phenomenon as the initial presentation. Methods One hundred and thirty-five outpatients with Raynaud' s phenomenon as the initial presentation who were diagnosed with connective tissue disease in the department of rheumatology of Peking Union Medical College Hospital from October 2012 to March 2013 were enrolled. Chest high-resolution computer tomography (HRCT) and ultrasonogram (UCG) examination were performed in all cases. Results There were 9 males and 126 females. Systemic lupus erythematosus (SLE) (45.9%), systemic sclerosis (SSc) (20.7%) and undifferentiated connective tissue disease (UCTD) ( 15.6% ) were the common final diagnosis of these patients. Systems involved in these patients were skin and mucous membrane (97 cases, 71.9% ), joint (86 cases, 63.7% ), lung involvement (72 cases, 53.3% ). Sixty-three cases had interstitial lung disease, including patients with SLE (29 cases,46.8% ), SSc ( 17cases, 60.0% ) and mixed connective tissue disease (6 cases, 83.3% ), etc. Thirty- seven cases had PAH, including patients with SLE ( 16cases, 25.8% ) , SSc ( 10 cases, 35.7% ) , undifferentiated connective tissue disease(4 cases, 19.7% )and primary Sjogren' s syndrome (2 cases, 28.6% ). Conclusion Raynaud' s phenomenon can be an early manifestation in a variety of autoimmune diseases, especially in SLE and SSc. Patients with Raynaud' s phenomenon are more likely to have pulmonary involvement, especially ILD or/and PAH, therefore, more attention should be paid to these patients. Chest HRCT and UCG are simple and effective methods for early screening of interstitial lung disease and pulmonary arterial hypertension earlier.
出处 《中华临床免疫和变态反应杂志》 2013年第4期346-350,共5页 Chinese Journal of Allergy & Clinical Immunology
关键词 雷诺现象 自身免疫性疾病 肺间质病变 肺动脉高压 Raynaud' s phenomenon autoimmune disease interstitial lung disease pulmonary arterial hypertension
  • 相关文献

参考文献9

  • 1赵书山,厉小梅,李向培,汪国生,钱龙,程涛,韦炜.原发性干燥综合征合并间质性肺病的临床特点[J].中华临床免疫和变态反应杂志,2008,2(1):32-36. 被引量:4
  • 2张奉春.弥漫性结缔组织病的肺间质病变[J].中华临床免疫和变态反应杂志,2008,2(3):171-172. 被引量:10
  • 3中华医学会心血管病学分会,中华心血管病杂志编辑委员会.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35:979-987.
  • 4季颖群,张卓莉,陆慰萱.结缔组织病相关肺动脉高压的临床分析[J].中华内科杂志,2006,45(6):467-471. 被引量:35
  • 5Carmona L, Gonzalez-Alvaro I, Balsa A, et al. Rheumatoid arthritis in Spain: occurrence of extra- articular manifestations and estimates of disease severity [J]. Ann Rheum Dis, 2003, 62:897-900.
  • 6Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease [ J ]. Clin Chest Med, 2004, 25:549-559.
  • 7Kallenberg CG. Raynaud' s phenomenon as an early sign of connective tissue diseases [ J ]. Vasa Suppl, 1992, 34 : 25-28.
  • 8连莉,徐胜前,徐建华.结缔组织病相关肺动脉高压79例临床分析[J].临床内科杂志,2010,27(5):338-340. 被引量:6
  • 9Mosca M, Tani C, Talarico R, et al. Autoimmun Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases [ J ].Autoimmun Rev, 2011, 10:256-258.

二级参考文献32

  • 1David B,Steve H,Gregory S.Medicla therapy for pulmonary arterial hypertension.Chest,2004,126:35-62.
  • 2Jing ZC,Xu XQ,Han ZY,et al.Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension.Chest,2007,132:373-379.
  • 3Cottin V.Pulmonary arterial hypertension in connective tissue disease.Rev Mal Respir,2006,23 (4 Suppl):S61-72.
  • 4McLaughlin VV,Presberg KW,Doyle R,et al.Prognosis of Pulmonary Arterial Hypertension.Chest,2004,126:78-92.
  • 5Chun-Hsiung Chen,Homg-An Chen,Hong-Pin Wang,et al.Pulmonary arterial hypertension in autoimmune disease:an analysis of 19 cases from a medical center in northern Taiwan.J Microbiol Immunol Infect,2006,29:162-168.
  • 6Anker SD,Doehner W,Rauchhaus M,et al.Uric acid and survival in chronic heart failure:validation and application in metabolic,functional,and hemodynamic staging.Circulation,2003,107:1991-1997.
  • 7Dawson J,Walters M.Uric acid and xanthine oxidase:future therapeutic targets in the prevention of cardiovascular disease.Br J Clin Pharmacol,2006,62:1-12.
  • 8Raymond RJ,Hinderliter AL,Willis PW,et al.Echecardiographic predictors of adverse outcomes in primary pulmonary hypertension.J Am Coil Cardiol,2002,39:1214-1219.
  • 9Hassoun PM.Pulmonary arterial hypertension complicating connective tissue diseases,Semin Respir Crit Care Med,2009,30:429-439.
  • 10Dorfmüller P,Humbert M,Perros FHum Pathol,et al.Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases.Hum Pathol,2007,38:893-902.

共引文献59

同被引文献57

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部